Cortical Thinning Associated with Age and CSF Biomarkers in Early Parkinson ’s Disease Is Modified by the SNCA rs356181 Polymorphism

The role of cerebrospinal fluid (CSF) biomarkers such as CSF α-synuclein and CSF tau in predicting cognitive decline in Parkinson’s disease (PD) continues to be inconsistent. Here, using a cohort of de novo PD patients with preserved cognition from the Parkinson’s Progression Markers Initiative (PPMI), we show that the SNCA rs356181 single nucleotide pol ymorphism (SNP) modulates the effect of these CSF biomarkers on cortical thinning. Depending on this SNP’s genotype, cortical atrophy was associated with either higher or lower CSF biomarker levels. Additionally, this SNP modified age-related atrophy. Importantly, the integrity of the brain region s where this phenomenon was observed correlated with cognitive measures. These results suggest that this genetic variation of the gene encoding the α-synuclein protein, known to be involved in the development of PD, also interferes in its subsequent neurodegeneration. Overall, our findings could sh ed light on the so far incongruent association of common CSF biomarkers with cognitive decline in PD.Neurodegener Dis 2018;18:233 –238
Source: Neurodegenerative Diseases - Category: Neurology Source Type: research